Zoetis Receives European Commission Marketing Authorization for Portela® (relfovetmab) to Alleviate Pain Associated with Osteoarthritis in Cats
My Vet Candy My Vet Candy

Zoetis Receives European Commission Marketing Authorization for Portela® (relfovetmab) to Alleviate Pain Associated with Osteoarthritis in Cats

Zoetis Inc. today announced that the European Commission has granted the company marketing authorization for Portela® (relfovetmab), making it the first monoclonal antibody (mAb) therapy with a three-month dosing interval approved for the alleviation of pain associated with osteoarthritis (OA) in cats.

Read More
Training the Next Generation of Wildlife Vets to Save Sumatran Elephants
My Vet Candy My Vet Candy

Training the Next Generation of Wildlife Vets to Save Sumatran Elephants

On the island of Sumatra, a Sumatran elephant in crisis doesn’t have much time. Injuries from snares, conflicts with humans, and habitat loss put these gentle giants at constant risk, and veterinary care is scarce. Enter the Wildlife Ambulance, a mobile veterinary unit based in Aceh Jaya Regency, providing not only urgent medical care but also hands-on training for the next generation of wildlife veterinarians.

Read More